Health Secretary Robert F. Kennedy Jr.’s approach to vaccine policy is raising concerns about a potential resurgence of preventable childhood diseases, according to a recent report by ProPublica. The article highlights that Kennedy is spreading doubts about the safety of vaccines and considering changes that could prompt manufacturers to leave the U.S. market, which may threaten access for parents seeking immunizations for their children.
The report recounts cases from 2022 and 2023 where unvaccinated infants in New York City suffered from invasive Haemophilus influenzae type b (Hib), a disease once nearly eradicated in the United States due to widespread vaccination. Dr. Adam Ratner, who treated these cases, described them as events that should never occur in modern medicine. "This should be a never event," Ratner told his colleagues after treating an infant with Hib.
ProPublica’s investigation found that trust in vaccines and access to them—two pillars of the U.S. immunization system—are now at risk due in part to federal leadership’s changing stance on vaccination. The article notes that Kennedy has previously founded an antivaccine group and compared child immunization efforts to historical atrocities, while also proposing policy shifts such as dropping six diseases from the routine childhood immunization schedule.
The American Academy of Pediatrics has boycotted meetings of the new advisory committee overseeing vaccine recommendations and sued to block some of Kennedy’s moves. A federal judge recently put on hold Kennedy's appointments to this panel and paused changes made to the childhood vaccine schedule after finding many new members appeared unqualified.
Global implications are also addressed: The U.S., under Kennedy’s direction, withdrew a $1.6 billion pledge from Gavi, an international vaccine aid group, affecting efforts abroad against diseases like diphtheria, rubella, and polio—diseases which can still reach American shores through travel or migration.
The article concludes with warnings from public health experts who fear that diminishing trust and access could allow deadly diseases once thought controlled or eliminated in the U.S. to return, according to ProPublica's detailed review available at the official roster page.
